
|Articles|January 16, 2006
Once-daily treatment for psoriasis approved
Advertisement
The FDA has approved Taclonex, a combination topical consisting of calcipotriene 0.005% and betamethasone dipropionate 0.064%, for the treatment of psoriasis vulgaris in adults. Warner Chilcott plans to launch the new ointment in the first half of 2006.
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Oral Semaglutide Shows Improvements in Blood Sugar, Cardiovascular Risk Factors
2
Q&A: Fentanyl, Opiophobia Concurrently Contribute to Ongoing Opioid Crisis
3
Expansion of OTC Contraceptive Could Fill Reproductive Health Disparities
4




















































































































































